Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-11-25

Clinical Trial Update: Remifentanil Requirement in Patients Receiving Surgical Treatment of Parkinson's Disease

View source ↗

Summary

A completed clinical trial update evaluating remifentanil requirements in patients undergoing surgical treatment for Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remifentanil (remifentanil)

Snippet

Sponsor: Changhai Hospital | Conditions: Parkinson's Disease | Status: COMPLETED